CARM1 and multiple sclerosis: Also, given its prominence in the structures observed in this study, R17, while unmodified here, is also the target of methylation by CARM1 [60], while deamination of R17 (together with R2 and R26) by PAD4 [61] also plays a role in the development of multiple sclerosis [62].